Clinical Research Provides New Options for Melanoma Patients

Sunday, May 6, 2012 - 8:42pm
Section Chief of Soft Tissue and Melanoma and Director of the IL-2 Program, Department of Medicine

Although tremendous strides have been made in the treatment of melanoma, there is still much work to be done. At Roswell Park we offer several clinical research studies focused on the discovery and advancement of promising therapies to treat this most dangerous form of skin cancer. These studies are improving care for many of our patients, providing them new options and new hope.

In the above video, I describe some of these ongoing clinical research studies. You can also click these links to learn more: